AISWARYA CHAUDHURI

Scopus Publications

Design and Synthesis of S-Acetophenylhydrazones of 5-Methyl-1,3,4-Thiadiazole-2-Thiol as SHP2 Inhibitory Agents
Rangan Mitra, Sandeep Kumar, Aiswarya Chaudhuri, Shreyasi Majumdar, Sairam Krishnamurthy, et al.
Chemistry and Biodiversity, 2025
We report herein the rational design, synthesis and evaluation of a library of 21 S‐acetophenylhydrazones of 5‐methyl‐1,3,4‐thiadiazole‐2‐thiol bearing a substituted benzylidene moiety (compounds 5a–5u). Compound 5f ((E)‐N'‐(2,6‐dichlorobenzylidene)‐2‐((5‐methyl‐1,3,4‐thiadiazol‐2‐yl)thio)acetohydrazide) emerged as the most potent SHP2 inhibitor (IC50 = 0.120 ± 0.006 µM). Further, cell‐based studies revealed its moderate yet best‐in‐library cytotoxicity against MCF‐7 cells (IC50 = 86.46 ± 2.32 µM) in a dose‐dependent manner. Compound 5f also exhibited in vitro anti‐survival (33% colony formation) and anti‐migratory effect (45% wound closure) on MCF‐7 cells upon treatment with sub‐IC50 dose. In vivo toxicological evaluation of compound 5f revealed excellent safety profile in mice at an oral dose of 2000 mg/kg BW. Our current study yielded a novel heterocyclic scaffold designed through systematic lead‐guided optimization displaying submicromolar SHP2 inhibitory activity. The lead molecule identified from in vitro studies was effective against the proliferation, survival and migration of human breast cancer cells with an excellent in vivo safety profile.
Oral delivery of dihydroartemisinin for the treatment of melanoma via bovine milk exosomes
Dulla Naveen Kumar, Aiswarya Chaudhuri, Deepa Dehari, Armin M. Gamper, Dinesh Kumar, et al.
Drug Delivery and Translational Research, 2025
Exploring combinations of dihydroartemisinin for cancer therapy: A comprehensive review
Komal Rani, Rohan Chand Sahu, Aiswarya Chaudhuri, Dulla Naveen Kumar, Sanchit Arora, et al.
Biochemical and Biophysical Research Communications, 2025
In vitro anticancer effects of frankincense and its nanoemulsions for enhanced cancer cell targeting
Rayya A. Al-Balushi, Aiswarya Chaudhuri, Raghuram Kandimalla, Ashanul Haque, Khalaf M. Alenezi, et al.
Frontiers in Pharmacology, 2025
IntroductionFrankincense has demonstrated promising in vitro anticancer activity. However, its conventional delivery methods face significant challenges due to limited oral bioavailability. To address these limitations, this study focuses on developing optimized nanoemulsions (NEs) of Frankincense oil (FO) to enhance its therapeutic efficacy.MethodsFrankincense resins were extracted and characterized using gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS), identifying key metabolites including isopinocarveol, α-thujene, p-cymene, carvone, germacrene A, and various methyl esters. FO-based nanoemulsions (FO-NEs) were prepared and optimized using a 3-factor, 3-level Box-Behnken Design (BBD), with 10% FO (v/v), 40% surfactant (cremophor EL), and co-surfactant (Transcutol P). The optimized FO-NEs were evaluated for particle size, polydispersity index (PDI), zeta potential, and morphology using scanning electron microscopy (SEM) and atomic force microscopy (AFM). Cytotoxicity, wound healing, mitochondrial membrane potential (MMP), and reactive oxygen species (ROS) assays were performed against breast cancer (MDA-MB-231, MDA-MB-231-TR) and lung cancer (A549, A549-TR, H1299) cell lines.ResultsThe optimized FO-NEs exhibited an average particle size of 65.1 ± 4.21 nm, a PDI of 0.258 ± 0.04, and a zeta potential of −22.3 ± 1.2 mV. SEM and AFM confirmed the spherical morphology of the FO-NEs. In vitro cytotoxicity studies revealed enhanced anticancer activity of FO-NEs (IC50 = 13.2 μg/mL) compared to free FO (IC50 = 22.5 μg/mL) against resistant breast cancer MDA-MB-231-TR cells. FO-NEs significantly improved cancer cell internalization, disrupted mitochondrial membrane potential, and increased ROS generation, leading to enhanced cytotoxic effects.DiscussionThe results demonstrate that nanoemulsion-based delivery significantly enhances the bioactivity and cellular uptake of frankincense oil compared to its free form. FO-NEs exhibit potent anticancer activity, particularly against drug-resistant cancer cell lines, suggesting their potential as a viable strategy for improving the therapeutic efficacy of frankincense in cancer treatment.
Non-traditional antibacterial therapeutic: Focus on safety, manufacturing, and regulatory dynamics
Deepa Dehari, Aiswarya Chaudhuri, Dulla Naveen Kumar, Ashish Kumar Agrawal
Emerging Paradigms for Antibiotic Resistant Infections Beyond the Pill, 2024
An Investigation of In Vitro Anti-Cancer Efficacy of Dihydroartemisinin-Loaded Bovine Milk Exosomes Against Triple-Negative Breast Cancer
Dulla Naveen Kumar, Aiswarya Chaudhuri, Udita Shiromani, Dinesh Kumar, Ashish Kumar Agrawal
AAPS Journal, 2024
Repurposing drugs offers several advantages, including reduced time and cost compared to developing new drugs from scratch. It leverages existing knowledge about drug safety, dosage, and pharmacokinetics, expediting the process of clinical trials and regulatory approval. Dihydroartemisinin (DHA) is a semi-synthetic and active metabolite of all artemisinin molecules and is FDA-approved for the treatment of malaria. Apart from having anti-malarial properties, DHA also possesses anticancer properties. However, its pharmacological actions are limited by toxicity and solubility problems. To overcome these challenges and enhance its anticancer effectiveness, we designed an exosomal formulation of DHA. We isolated exosomes from bovine milk using differential ultracentrifugation and loaded DHA using sonication. Scanning and transition electron microscopy revealed a size of roughly 100 nm, with a spherical shape. Furthermore, in pH 7.4 and 5.5, the exosomes exhibited burst release followed by sustained release. Multiple in vitro cell culture tests demonstrated that Exo-DHA exhibited enhanced anticancer activity, including cytotoxicity, cellular uptake, generation of reactive oxygen species (ROS), disruption of mitochondrial membrane potential, and inhibition of colony formation. Additional evidence supporting Exo-DHA's anti-migration ability came from transwell migration and scratch assays. Based on these results, it was concluded that the anticancer efficacy of DHA was improved when loaded into bovine milk-derived exosomes. While the in vitro results are encouraging, more in vivo testing in suitable animal models and biochemical marker analysis are warranted.
Corrigendum to “Exosomes improved the in vitro anti-melanoma efficacy of dihydroartemisinin” [J. Drug Delivery Sci. Tech. 9 (2024) 105957] (Journal of Drug Delivery Science and Technology (2024) 99, (S1773224724006269), (10.1016/j.jddst.2024.105957))
Dulla Naveen Kumar, Aiswarya Chaudhuri, Deepa Dehari, Armin M. Gamper, Dinesh Kumar, et al.
Journal of Drug Delivery Science and Technology, 2024
Exosomes improved the in vitro anti-melanoma efficacy of dihydroartemisinin
Dulla Naveen Kumar, Aiswarya Chaudhuri, Deepa Dehari, Armin M. Gamper, Dinesh Kumar, et al.
Journal of Drug Delivery Science and Technology, 2024
Azacoumarin-based “turn-on” fluorescent probe for the detection and imaging of hydrogen peroxide in living cells
Samarpita Das, Aiswarya Chaudhuri, Harish K. Indurthi, Ashish K. Agrawal, Deepak K. Sharma
Organic and Biomolecular Chemistry, 2024
Herein, we demonstrate azacoumarins as potential fluorophores and their application in the synthesis of a “turn-on” fluorescent probe (PYCB) for the detection of H2O2 using a carboxy benzyl boronic pinacol ester as the peroxide recognition unit.
Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer
Aiswarya Chaudhuri, Dulla Naveen Kumar, Dinesh Kumar, Ashish Kumar Agrawal
European Journal of Pharmaceutics and Biopharmaceutics, 2024
Design, Synthesis and Evaluation of Thioacetamide-Tethered Thiadiazole-1,2,4-Triazole Hybrids as SHP2 Inhibitors for Cancer Therapy
Rangan Mitra, Sandeep Kumar, Aiswarya Chaudhuri, Ashish Kumar Agrawal, Senthil Raja Ayyannan
Chemistryselect, 2024
Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach
Aiswarya Chaudhuri, Dulla Naveen Kumar, Saurabh Kumar Srivastava, Dinesh Kumar, Umesh Kumar Patil, et al.
Pharmaceutics, 2024
Enhanced Therapeutic Efficacy Against Melanoma through Exosomal Delivery of Hesperidin
Dulla Naveen Kumar, Aiswarya Chaudhuri, Deepa Dehari, Armin M. Gamper, Dinesh Kumar, et al.
Molecular Pharmaceutics, 2024
Bacteriophage entrapped chitosan microgel for the treatment of biofilm-mediated polybacterial infection in burn wounds
Deepa Dehari, Dulla Naveen Kumar, Aiswarya Chaudhuri, Akshay Kumar, Rajesh Kumar, et al.
International Journal of Biological Macromolecules, 2023
Impact of the Drug Loading Method on the Drug Distribution and Biological Efficacy of Exosomes
Dulla Naveen Kumar, Aiswarya Chaudhuri, Dinesh Kumar, Sanjay Singh, Ashish Kumar Agrawal
AAPS Pharmscitech, 2023
Recent advancements in nanotechnology-based bacteriophage delivery strategies against bacterial ocular infections
Rohit Patil, Deepa Dehari, Aiswarya Chaudhuri, Dulla Naveen Kumar, Dinesh Kumar, et al.
Microbiological Research, 2023
A Bacteriophage-Loaded Microparticle Laden Topical Gel for the Treatment of Multidrug-Resistant Biofilm-Mediated Burn Wound Infection
Deepa Dehari, Aiswarya Chaudhuri, Dulla Naveen Kumar, Meraj Anjum, Rajesh Kumar, et al.
AAPS Pharmscitech, 2023
A Bacteriophage Microgel Effectively Treats the Multidrug-Resistant Acinetobacter baumannii Bacterial Infections in Burn Wounds
Deepa Dehari, Aiswarya Chaudhuri, Dulla Naveen Kumar, Rohit Patil, Mayank Gangwar, et al.
Pharmaceuticals, 2023
Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, Rohit Patil, Sanjay Singh, et al.
Cancers, 2023
Nanotherapeutics in autophagy: a paradigm shift in cancer treatment
Shloka Negi, Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, Sanjay Singh, et al.
Drug Delivery and Translational Research, 2022
Polymeric micelles: A novel drug delivery system for the treatment of breast cancer
Aiswarya Chaudhuri, Korra Ramesh, Dulla Naveen Kumar, Deepa Dehari, Sanjay Singh, et al.
Journal of Drug Delivery Science and Technology, 2022
Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy
Aiswarya Chaudhuri, Dulla Naveen Kumar, Rasheed A. Shaik, Basma G. Eid, Ashraf B. Abdel-Naim, et al.
International Journal of Molecular Sciences, 2022
Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer
Dulla Naveen Kumar, Aiswarya Chaudhuri, Deepa Dehari, Anusmita Shekher, Subash C. Gupta, et al.
Life, 2022
Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, Sanjay Singh, Pradeep Kumar, et al.
Pharmaceuticals, 2022
Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application
Dulla Naveen Kumar, Aiswarya Chaudhuri, Farrukh Aqil, Deepa Dehari, Radha Munagala, et al.
Cancers, 2022

RECENT SCHOLAR PUBLICATIONS

Design and Synthesis of S ‐Acetophenylhydrazones of 5‐Methyl‐1,3,4‐Thiadiazole‐2‐Thiol as SHP2 Inhibitory Agents
R Mitra, S Kumar, A Chaudhuri, S Majumdar, S Krishnamurthy, ...
Chemistry & Biodiversity 22 (9), e202402997 , 2025
2025
Oral delivery of dihydroartemisinin for the treatment of melanoma via bovine milk exosomes
DN Kumar, A Chaudhuri, D Dehari, AM Gamper, D Kumar, AK Agrawal
Drug Delivery and Translational Research 15 (8), 2862-2877 , 2025
2025
Citations: 12
Exploring combinations of dihydroartemisinin for cancer therapy: A comprehensive review
K Rani, RC Sahu, A Chaudhuri, DN Kumar, S Arora, D Kumar, ...
Biochemical and Biophysical Research Communications 765, 151854 , 2025
2025
Citations: 11
In vitro anticancer effects of frankincense and its nanoemulsions for enhanced cancer cell targeting
RA Al-Balushi, A Chaudhuri, R Kandimalla, A Haque, KM Alenezi, ...
Frontiers in Pharmacology 16, 1403780 , 2025
2025
Citations: 5
Non-Traditional Antibacterial Therapeutic: Focus on Safety, Manufacturing, and Regulatory Dynamics
D Dehari, A Chaudhuri, DN Kumar, AK Agrawal
Emerging Paradigms for Antibiotic-Resistant Infections: Beyond the Pill, 787-810 , 2024
2024
Citations: 4
Corrigendum to “Exosomes improved the in vitro anti-melanoma efficacy of dihydroartemisinin”[J. Drug Delivery Sci. Tech. 9 (2024) 105957]
DN Kumar, A Chaudhuri, D Dehari, AM Gamper, D Kumar, AK Agrawal
Journal of Drug Delivery Science and Technology 99, 105993 , 2024
2024
Exosomes improved the in vitro anti-melanoma efficacy of dihydroartemisinin
DN Kumar, A Chaudhuri, D Dehari, AM Gamper, D Kumar, AK Agrawal
Journal of Drug Delivery Science and Technology 99, 105957 , 2024
2024
Citations: 4
An Investigation of In Vitro Anti-Cancer Efficacy of Dihydroartemisinin-Loaded Bovine Milk Exosomes Against Triple-Negative Breast Cancer
DN Kumar, A Chaudhuri, U Shiromani, D Kumar, AK Agrawal
The AAPS journal 26 (5), 91 , 2024
2024
Citations: 19
Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer
A Chaudhuri, DN Kumar, D Kumar, AK Agrawal
European Journal of Pharmaceutics and Biopharmaceutics 201, 114386 , 2024
2024
Citations: 15
Design, Synthesis and Evaluation of Thioacetamide‐Tethered Thiadiazole‐1, 2, 4‐Triazole Hybrids as SHP2 Inhibitors for Cancer Therapy
R Mitra, S Kumar, A Chaudhuri, AK Agrawal, SR Ayyannan
ChemistrySelect 9 (27), e202401602 , 2024
2024
Citations: 1
Combinatorial delivery of docetaxel-and erlotinib-loaded functionalized nanostructured lipid carriers for the treatment of triple-negative breast cancer using quality-by-design …
A Chaudhuri, DN Kumar, SK Srivastava, D Kumar, UK Patil, AS Parmar, ...
Pharmaceutics 16 (7), 926 , 2024
2024
Citations: 15
Enhanced therapeutic efficacy against melanoma through exosomal delivery of hesperidin
DN Kumar, A Chaudhuri, D Dehari, AM Gamper, D Kumar, AK Agrawal
Molecular pharmaceutics 21 (6), 3061-3076 , 2024
2024
Citations: 28
Azacoumarin-based “turn-on” fluorescent probe for the detection and imaging of hydrogen peroxide in living cells
S Das, A Chaudhuri, HK Indurthi, AK Agrawal, DK Sharma
Organic & Biomolecular Chemistry 22 (36), 7332-7336 , 2024
2024
Citations: 6
Bacteriophage entrapped chitosan microgel for the treatment of biofilm-mediated polybacterial infection in burn wounds
D Dehari, DN Kumar, A Chaudhuri, A Kumar, R Kumar, D Kumar, S Singh, ...
International Journal of Biological Macromolecules 253, 127247 , 2023
2023
Citations: 23
A bacteriophage-loaded microparticle laden topical gel for the treatment of multidrug-resistant biofilm-mediated burn wound infection
D Dehari, A Chaudhuri, DN Kumar, M Anjum, R Kumar, A Kumar, ...
AAPS pharmscitech 24 (6), 165 , 2023
2023
Citations: 12
Impact of the drug loading method on the drug distribution and biological efficacy of exosomes
DN Kumar, A Chaudhuri, D Kumar, S Singh, AK Agrawal
Aaps Pharmscitech 24 (6), 166 , 2023
2023
Citations: 50
Recent advancements in nanotechnology-based bacteriophage delivery strategies against bacterial ocular infections
R Patil, D Dehari, A Chaudhuri, DN Kumar, D Kumar, S Singh, G Nath, ...
Microbiological research 273, 127413 , 2023
2023
Citations: 39
A Bacteriophage Microgel Effectively Treats the Multidrug-Resistant Acinetobacter baumannii Bacterial Infections in Burn Wounds
D Dehari, A Chaudhuri, DN Kumar, R Patil, M Gangwar, S Rastogi, ...
Pharmaceuticals 16 (7), 942 , 2023
2023
Citations: 28
Endorsement of TNBC biomarkers in precision therapy by nanotechnology
A Chaudhuri, DN Kumar, D Dehari, R Patil, S Singh, D Kumar, ...
Cancers 15 (9), 2661 , 2023
2023
Citations: 31
Introduction to smart polymers and their application. Smart Polymeric Nano-Constructs in Drug Delivery
A Chaudhuri, KK Sandha, AK Agrawal, PN Gupta
Academic Press , 2023
2023
Citations: 20

MOST CITED SCHOLAR PUBLICATIONS

Docetaxel: An update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer
M Imran, S Saleem, A Chaudhuri, J Ali, S Baboota
Journal of Drug Delivery Science and Technology 60, 101959 , 2020
2020
Citations: 171
Lipid-based nanoparticles as a pivotal delivery approach in Triple Negative Breast Cancer (TNBC) therapy
A Chaudhuri, DN Kumar, RA Shaik, BG Eid, AB Abdel-Naim, S Md, ...
International Journal of Molecular Sciences 23 (10068), 1-39 , 2022
2022
Citations: 90
Exosomes as emerging drug delivery and diagnostic modality for breast cancer: recent advances in isolation and application
DN Kumar, A Chaudhuri, F Aqil, D Dehari, R Munagala, S Singh, ...
Cancers 14 (6), 1435 , 2022
2022
Citations: 85
Polymeric micelles: A novel drug delivery system for the treatment of breast cancer
A Chaudhuri, K Ramesh, DN Kumar, D Dehari, S Singh, D Kumar, ...
Journal of Drug Delivery Science and Technology 77, 103886 , 2022
2022
Citations: 81
Combination therapy comprising paclitaxel and 5-fluorouracil by using folic acid functionalized bovine milk exosomes improves the therapeutic efficacy against breast cancer
DN Kumar, A Chaudhuri, D Dehari, A Shekher, SC Gupta, S Majumdar, ...
Life 12 (8), 1143 , 2022
2022
Citations: 79
Impact of the drug loading method on the drug distribution and biological efficacy of exosomes
DN Kumar, A Chaudhuri, D Kumar, S Singh, AK Agrawal
Aaps Pharmscitech 24 (6), 166 , 2023
2023
Citations: 50
Emergence of nanotechnology as a powerful cavalry against triple-negative breast cancer (TNBC)
A Chaudhuri, DN Kumar, D Dehari, S Singh, P Kumar, PK Bolla, D Kumar, ...
Pharmaceuticals 15 (5), 542 , 2022
2022
Citations: 48
Designing and development of omega-3 fatty acid based self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel with enhanced biopharmaceutical attributes for management …
A Chaudhuri, N Shrivastava, S Kumar, AK Singh, J Ali, S Baboota
Journal of Drug Delivery Science and Technology 68, 103117 , 2022
2022
Citations: 41
Recent advancements in nanotechnology-based bacteriophage delivery strategies against bacterial ocular infections
R Patil, D Dehari, A Chaudhuri, DN Kumar, D Kumar, S Singh, G Nath, ...
Microbiological research 273, 127413 , 2023
2023
Citations: 39
Endorsement of TNBC biomarkers in precision therapy by nanotechnology
A Chaudhuri, DN Kumar, D Dehari, R Patil, S Singh, D Kumar, ...
Cancers 15 (9), 2661 , 2023
2023
Citations: 31
Natural, synthetic and their combinatorial nanocarriers based drug delivery system in the treatment paradigm for wound healing via dermal targeting
MK Iqubal, S Saleem, A Iqubal, A Chaudhuri, FH Pottoo, J Ali, S Baboota
Current Pharmaceutical Design 26 (36), 4551-4568 , 2020
2020
Citations: 31
Enhanced therapeutic efficacy against melanoma through exosomal delivery of hesperidin
DN Kumar, A Chaudhuri, D Dehari, AM Gamper, D Kumar, AK Agrawal
Molecular pharmaceutics 21 (6), 3061-3076 , 2024
2024
Citations: 28
A Bacteriophage Microgel Effectively Treats the Multidrug-Resistant Acinetobacter baumannii Bacterial Infections in Burn Wounds
D Dehari, A Chaudhuri, DN Kumar, R Patil, M Gangwar, S Rastogi, ...
Pharmaceuticals 16 (7), 942 , 2023
2023
Citations: 28
Nanotherapeutics in autophagy: A paradigm shift in cancer treatment
S Negi, A Chaudhuri, DN Kumar, D Dehari, S Singh, AK Agrawal
Drug Delivery and Translational Research 12 (11), 2589-2612 , 2022
2022
Citations: 28
Bacteriophage entrapped chitosan microgel for the treatment of biofilm-mediated polybacterial infection in burn wounds
D Dehari, DN Kumar, A Chaudhuri, A Kumar, R Kumar, D Kumar, S Singh, ...
International Journal of Biological Macromolecules 253, 127247 , 2023
2023
Citations: 23
Targeted delivery of natural bioactives and lipid-nanocargos against signaling pathways involved in skin cancer
MK Iqubal, A Chaudhuri, A Iqubal, S Saleem, MM Gupta, A Ahuja, J Ali, ...
Current Medicinal Chemistry 28 (39), 8003-8035 , 2021
2021
Citations: 22
Therapeutic potential of venom peptides: Insights in the nanoparticle-mediated venom formulations
AV Joglekar, D Dehari, MM Anjum, N Dulla, A Chaudhuri, S Singh, ...
Future Journal of Pharmaceutical Sciences 8 (1), 34 , 2022
2022
Citations: 21
Herbal cosmeceuticals: New opportunities in cosmetology
M Aqil, A Chaudhuri, A Qadir
Trends in Phytochemical Research 4 (3), 117-142 , 2020
2020
Citations: 21
Introduction to smart polymers and their application. Smart Polymeric Nano-Constructs in Drug Delivery
A Chaudhuri, KK Sandha, AK Agrawal, PN Gupta
Academic Press , 2023
2023
Citations: 20
An Investigation of In Vitro Anti-Cancer Efficacy of Dihydroartemisinin-Loaded Bovine Milk Exosomes Against Triple-Negative Breast Cancer
DN Kumar, A Chaudhuri, U Shiromani, D Kumar, AK Agrawal
The AAPS journal 26 (5), 91 , 2024
2024
Citations: 19

AISWARYA CHAUDHURI

EDUCATION

RESEARCH INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS